Us Goods Regulation
- All
- News
- Videos
-
Sun Pharma Says Gujarat Facility Listed Under US Regulator's Import Alert
The import alert means all future shipments of products made at Halol can be refused admission to the US market until the facility becomes compliant with the FDA's Current Good Manufacturing Practice standards,
-
High Protein Diet: 5 Diet Tips To Load Up On Protein In Winters
Since a lot of us lose sight of healthy eating during winters, it is important you not only include protein in your diet but also distribute it well throughout the day.
-
US Said to Weigh New Regulations to Further Restrict Huawei Suppliers
The US government may expand its power to stop more foreign shipments of products with US technology to Huawei.
-
Zuckerberg Says Facebook Plans to Follow EU's GDPR Rules Worldwide
Zuckerberg acknowledged Facebook planned to follow the bloc's strict new rules worldwide.
-
Rujuta Diwekar Tells Us The Many Health Benefits Of Til (Sesame Seeds)
Did you know? Til (sesame seeds) can help in burning fat
-
Does Apple Cider Actaully Make You Lose Weight?
Apple cider has always been considered as an essential diet constituent for weight loss. If you scour the internet you'll find the same information all over. But the real question is that if this ingredient even helps us in losing weight or not.
-
US Regulator's Scrutiny On Indian Drug Makers To Remain Intense: Crisil
Regulatory scrutiny of the US Food and Drug Administration (FDA) for domestic pharmaceutical facilities is expected to remain intense over the medium term, rating agency Crisil said on Wednesday.
-
FDC Receives Observations From US Regulator For Waluj Plant
Drug firm FDC Ltd has received two observations from the US Food and Drug Administration (FDA) related to current good manufacturing practice (cGMP) norms for its manufacturing facility situated at Waluj in Maharashtra.
-
US Regulator Issues Warning Letter to Emcure Pharma
The US Food and DrugAdministration (FDA) has issued a warning letter to EmcurePharmaceuticals for violating current good manufacturingpractice norms at its Pune-based plant.
-
Sun Pharma to Ask US Regulator for Halol Reinspection in March Quarter
Drug major Sun Pharmaceutical Industries may ask the US Food and Drug Administration (FDA) in the first quarter of next fiscal year for reinspection of its Halol facility as it undertakes remediation measures to make the plant compliant to good manufacturing practice norms.
-
US Drug Regulator Warns Dr Reddy's of Import Ban
The US regulator said it had found several violations with regard to current good manufacturing practices (CGMP) at three of its plants.
-
Novartis Gets US Regulator Warning Letter for 2 Plants in India
The warning letter observations follow USFDA inspection at both sites in August 2014 and are related to deficiencies in current good manufacturing practice (cGMP) for finished pharmaceuticals, it added.
-
Drug Regulator Upgrades Jubilant Life's US Plant Status
This upgradation by the USFDA from Official Action Indicated (OAI) to VAI is "indicative of the current good manufacturing practice (cGMP) status at the facility" since receiving the warning letter in 2013, the drug maker added.
-
EU, UK evaluating FDA findings on Ranbaxy's Toansa facility
Days after the US Food and Drug Administration (FDA) banned import of Ranbaxy products to America from its Toansa plant, health regulators of the EU and the UK have said they are evaluating the FDA inspection findings to assess if deviations from good manufacturing practice (GMP) have any implication in their markets.
-
Ranbaxy shares slump; US regulator raises concerns about India plants
All of Ranbaxy's India-based factories are currently banned by the FDA from exporting medicines to the United States, the company's largest market, after the regulator's inspection found violation of its so-called good manufacturing practices.
-
Sun Pharma Says Gujarat Facility Listed Under US Regulator's Import Alert
The import alert means all future shipments of products made at Halol can be refused admission to the US market until the facility becomes compliant with the FDA's Current Good Manufacturing Practice standards,
-
High Protein Diet: 5 Diet Tips To Load Up On Protein In Winters
Since a lot of us lose sight of healthy eating during winters, it is important you not only include protein in your diet but also distribute it well throughout the day.
-
US Said to Weigh New Regulations to Further Restrict Huawei Suppliers
The US government may expand its power to stop more foreign shipments of products with US technology to Huawei.
-
Zuckerberg Says Facebook Plans to Follow EU's GDPR Rules Worldwide
Zuckerberg acknowledged Facebook planned to follow the bloc's strict new rules worldwide.
-
Rujuta Diwekar Tells Us The Many Health Benefits Of Til (Sesame Seeds)
Did you know? Til (sesame seeds) can help in burning fat
-
Does Apple Cider Actaully Make You Lose Weight?
Apple cider has always been considered as an essential diet constituent for weight loss. If you scour the internet you'll find the same information all over. But the real question is that if this ingredient even helps us in losing weight or not.
-
US Regulator's Scrutiny On Indian Drug Makers To Remain Intense: Crisil
Regulatory scrutiny of the US Food and Drug Administration (FDA) for domestic pharmaceutical facilities is expected to remain intense over the medium term, rating agency Crisil said on Wednesday.
-
FDC Receives Observations From US Regulator For Waluj Plant
Drug firm FDC Ltd has received two observations from the US Food and Drug Administration (FDA) related to current good manufacturing practice (cGMP) norms for its manufacturing facility situated at Waluj in Maharashtra.
-
US Regulator Issues Warning Letter to Emcure Pharma
The US Food and DrugAdministration (FDA) has issued a warning letter to EmcurePharmaceuticals for violating current good manufacturingpractice norms at its Pune-based plant.
-
Sun Pharma to Ask US Regulator for Halol Reinspection in March Quarter
Drug major Sun Pharmaceutical Industries may ask the US Food and Drug Administration (FDA) in the first quarter of next fiscal year for reinspection of its Halol facility as it undertakes remediation measures to make the plant compliant to good manufacturing practice norms.
-
US Drug Regulator Warns Dr Reddy's of Import Ban
The US regulator said it had found several violations with regard to current good manufacturing practices (CGMP) at three of its plants.
-
Novartis Gets US Regulator Warning Letter for 2 Plants in India
The warning letter observations follow USFDA inspection at both sites in August 2014 and are related to deficiencies in current good manufacturing practice (cGMP) for finished pharmaceuticals, it added.
-
Drug Regulator Upgrades Jubilant Life's US Plant Status
This upgradation by the USFDA from Official Action Indicated (OAI) to VAI is "indicative of the current good manufacturing practice (cGMP) status at the facility" since receiving the warning letter in 2013, the drug maker added.
-
EU, UK evaluating FDA findings on Ranbaxy's Toansa facility
Days after the US Food and Drug Administration (FDA) banned import of Ranbaxy products to America from its Toansa plant, health regulators of the EU and the UK have said they are evaluating the FDA inspection findings to assess if deviations from good manufacturing practice (GMP) have any implication in their markets.
-
Ranbaxy shares slump; US regulator raises concerns about India plants
All of Ranbaxy's India-based factories are currently banned by the FDA from exporting medicines to the United States, the company's largest market, after the regulator's inspection found violation of its so-called good manufacturing practices.
